Petition urges action on vitamin B6 form ban

By Shane Starling

- Last updated on GMT

Related tags: Pharmacology

The Alliance for Natural Health USA (ANH-USA) is urging people to sign a petition against the market withdrawal of P5P, a natural compound linked with vitamin B6 or Pyridoxamine – in dietary supplement form.

The ANH-USA said the FDA had supported a citizen’s petition lodged by the pharma firm, BioStratum, which brought Pyridoxamine under its control and warned a compound natural B6 converted to in the body – P5P – could also come under drug company control.

Medicure Pharma had lodged a petition for that to occur, ANH-USA said.

ANH-USA highlighted the Medicure Pharma petition that spelled out its motivation for lodging the petition.

“Pharmaceutical companies developing new drugs must be protected from companies that may seek to market the ingredients in those drugs as dietary supplements,”​ the petition reads.

“The marketing of such products has the potential to undermine the incentive for the development of new drugs because many people may choose to purchase the supplements rather than the drugs.”

The ANH-USA said: “This is not of course a case of supplement producers creating a product to compete with an existing prescription drug. It is just the reverse. P5P, the natural and bioactive form of B6, has existed in food for as long as there have been humans and has been available as a supplement for years. Medicure seems to be saying: If it seems profitable, let’s just turn a critical vitamin, one essential for human life, into a drug, make it available only by subscription, and mark up the price. This is truly outrageous.”

Medicure was unavailable for comment at the time of publication.

The petition can be found here​.

Related news

Show more

Related products

show more

Whitepaper: Optimizing immunity with vitamin D

Whitepaper: Optimizing immunity with vitamin D

DSM Nutritional Products | 16-Jun-2022 | Technical / White Paper

With vitamin D science evolving rapidly since the COVID-19 pandemic, our new whitepaper breaks down the latest research on the role of vitamin D in supporting...

Custom Premix Solutions

Custom Premix Solutions

Glanbia Nutritionals | 14-Jun-2022 | Product Presentation

Developing a finished product is complicated.

Meeting the Retail Dietary Supplement Requirements

Meeting the Retail Dietary Supplement Requirements

Gemini Pharmaceuticals | 06-Jun-2022 | Technical / White Paper

Recently, retailers have been requiring additional assurances that the dietary supplement products they offer for sale meet label claims. Brand Owners...

Related suppliers

Follow us


View more